Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 STERISSmith & NephewDemant A/SShandong Weigao Group Medical PolymerWound Management Technologies
SymbolNYSE:STENYSE:SNNOTCMKTS:WILYYOTCMKTS:SHWGFOTCMKTS:WNDM
Price Information
Current Price$199.15$38.50$23.19$1.67$31.57
52 Week RangeBuyHoldHoldN/AN/A
MarketRank™
Overall Score2.12.10.80.00.9
Analysis Score1.33.20.00.00.0
Community Score2.11.91.90.02.6
Dividend Score3.32.50.00.00.0
Ownership Score1.70.00.00.01.7
Earnings & Valuation Score1.93.11.90.00.0
Analyst Ratings
Consensus RecommendationBuyHoldHoldN/AN/A
Consensus Price Target$214.25$47.17N/AN/AN/A
% Upside from Price Target7.58% upside22.51% upsideN/AN/AN/A
Trade Information
Market Cap$17.00 billion$16.92 billion$11.16 billion$7.55 billion$7.47 billion
Beta0.590.70.230.611.9
Average Volume623,419419,9231,42633,050137,966
Sales & Book Value
Annual Revenue$3.03 billion$5.14 billion$2.24 billion$1.50 billion$5.84 million
Price / Sales5.613.294.985.041,279.25
Cashflow$8.23 per share$2.84 per share$0.64 per share$0.06 per shareN/A
Price / Cash24.2113.5536.4826.47N/A
Book Value$40.17 per share$11.76 per share$2.34 per share$0.54 per shareN/A
Price / Book4.963.279.913.09
Profitability
Net Income$407.61 million$600 million$219.15 million$266.95 million$-600,000.00
EPS$5.64$2.04$0.45N/AN/A
Trailing P/E Ratio40.4018.8751.530.000.00
Forward P/E Ratio29.0319.9535.14
P/E GrowthN/A4.91N/AN/AN/A
Net Margins13.97%N/AN/AN/A-10.28%
Return on Equity (ROE)14.44%N/AN/AN/A-39.28%
Return on Assets (ROA)9.32%N/AN/AN/A-21.49%
Dividend
Annual Payout$1.60$0.90N/AN/AN/A
Dividend Yield0.80%2.34%N/AN/AN/A
Three-Year Dividend Growth30.51%102.70%N/AN/AN/A
Payout Ratio28.37%44.12%N/AN/AN/A
Years of Consecutive Dividend Growth15 Years1 YearsN/AN/AN/A
Debt
Debt-to-Equity Ratio0.28%0.50%0.33%0.22%1.35%
Current Ratio2.64%2.18%0.68%3.22%2.42%
Quick Ratio2.00%1.04%0.47%2.87%2.42%
Ownership Information
Institutional Ownership Percentage90.01%8.91%N/AN/AN/A
Insider Ownership Percentage1.20%1.00%N/AN/A75.40%
Miscellaneous
Employees13,00018,00016,59110,15313
Shares Outstanding85.35 million439.44 million481.38 million4.52 billion236.64 million
Next Earnings Date5/12/2021 (Estimated)N/AN/A6/29/2021 (Estimated)N/A
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Europe Bioactive Wound Management Market is expected to reach US$ 676.54 Million by 2027 with CAGR of 7.9% | Business Market InsightsEurope Bioactive Wound Management Market is expected to reach US$ 676.54 Million by 2027 with CAGR of 7.9% | Business Market Insights
ksusentinel.com - April 9 at 5:43 PM
Advanced Wound Care Management Market Projected to Expand at a CAGR of 5.8% from 2018 to 2026Advanced Wound Care Management Market Projected to Expand at a CAGR of 5.8% from 2018 to 2026
sbwire.com - April 8 at 2:59 PM
Surgical Sutures can Now Deliver Drugs, Prevent Infections and Treat WoundsSurgical Sutures can Now Deliver Drugs, Prevent Infections and Treat Wounds
medindia.net - April 8 at 9:59 AM
Wound Cleanser Products Market 2021 : Top countries Data, Market Size, In-Depth Analysis with Booming Trends and Segmentation Forecast to 2026Wound Cleanser Products Market 2021 : Top countries Data, Market Size, In-Depth Analysis with Booming Trends and Segmentation Forecast to 2026
marketwatch.com - April 8 at 4:58 AM
Next-Generation Surgical Sutures Inspired by Human Tendons Can Deliver Drugs, Prevent Infections, and Monitor WoundsNext-Generation Surgical Sutures Inspired by Human Tendons Can Deliver Drugs, Prevent Infections, and Monitor Wounds
scitechdaily.com - April 7 at 5:28 PM
Next-generation sutures can deliver drugs, prevent infections and monitor woundsNext-generation sutures can deliver drugs, prevent infections and monitor wounds
medicalxpress.com - April 7 at 5:28 PM
Racing For Heroes selects Gen2 Technologies as a Key Technology PartnerRacing For Heroes selects Gen2 Technologies as a Key Technology Partner
prnewswire.com - April 7 at 12:28 PM
Advanced Wound Care Management Market Size Estimated to Reach $16,500 Million by 2026Advanced Wound Care Management Market Size Estimated to Reach $16,500 Million by 2026
marketwatch.com - April 7 at 12:28 PM
Advanced Wound Care Market in North America 2021 | Regional Insights & Growth Forecast To 2027Advanced Wound Care Market in North America 2021 | Regional Insights & Growth Forecast To 2027
ksusentinel.com - April 6 at 7:59 PM
Scapa Healthcare Boosts Manufacturing Capabilities at its Hydrocolloid Technology Center in Orangeburg, New YorkScapa Healthcare Boosts Manufacturing Capabilities at its Hydrocolloid Technology Center in Orangeburg, New York
finance.yahoo.com - April 6 at 2:58 PM
Wounds Measurement Devices Market Size to Grow at a CAGR of 4.7% During the Forecast Period 2021–2026Wounds Measurement Devices Market Size to Grow at a CAGR of 4.7% During the Forecast Period 2021–2026
marketwatch.com - April 6 at 2:58 PM
Perceptive Solutions Releases WoundZoom Mobile Digital Wound Management ApplicationPerceptive Solutions Releases WoundZoom Mobile Digital Wound Management Application
apnews.com - April 6 at 9:57 AM
Tissue Scaffolds Market to Grow by USD 1.20 Billion |Increasing Prevalence of Chronic and Acute Wounds to Drive Growth | TechnavioTissue Scaffolds Market to Grow by USD 1.20 Billion |Increasing Prevalence of Chronic and Acute Wounds to Drive Growth | Technavio
prnewswire.com - April 5 at 7:23 AM
Wound Debridement Products Market to Gain Impetus in Chronic Wound Treatments from Burns and Lifestyle AilmentsWound Debridement Products Market to Gain Impetus in Chronic Wound Treatments from Burns and Lifestyle Ailments
fmiblog.com - April 1 at 8:36 AM
SANUWAVE Health Announces Expansion of Ametus Group Distribution PartnershipSANUWAVE Health Announces Expansion of Ametus Group Distribution Partnership
markets.businessinsider.com - March 30 at 8:44 AM
Essity Selected To Join Global Task Force On Prophylactic Dressing Standards In Wound CareEssity Selected To Join Global Task Force On Prophylactic Dressing Standards In Wound Care
markets.businessinsider.com - March 30 at 8:44 AM
The Cybersecurity 202: Facebook is getting more public about taking on foreign spiesThe Cybersecurity 202: Facebook is getting more public about taking on foreign spies
msn.com - March 25 at 10:54 AM
Corstrata Hires Client Success Manager for Provider ServicesCorstrata Hires Client Success Manager for Provider Services
wfmz.com - March 24 at 7:13 PM
MediWound Hosting Analyst Day Webinar on EscharEx – Enzymatic Debridement Agent for Chronic WoundsMediWound Hosting Analyst Day Webinar on EscharEx – Enzymatic Debridement Agent for Chronic Wounds
finance.yahoo.com - March 24 at 7:13 PM
Arch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 ...Arch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 ...
apnews.com - March 24 at 2:13 PM
Arch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 Topical Wound TreatmentArch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 Topical Wound Treatment
finance.yahoo.com - March 24 at 2:13 PM
HMP Global Releases Updated On-Demand Platform for its Wound Certification Prep CourseHMP Global Releases Updated On-Demand Platform for its Wound Certification Prep Course
finance.yahoo.com - March 24 at 2:13 PM
Traditional Wound Management Market to Hit $7.20 Billion By 2028Traditional Wound Management Market to Hit $7.20 Billion By 2028
arnnet.com.au - March 23 at 7:40 AM
The PSB Mega-Mergers: New Entities Causing Raw Wounds at All Levels -Part2The PSB Mega-Mergers: New Entities Causing Raw Wounds at All Levels -Part2
moneylife.in - March 23 at 1:38 AM
A multiomics approach to identify host-microbe alterations associated with infection severity in diabetic foot infections: a pilot studyA multiomics approach to identify host-microbe alterations associated with infection severity in diabetic foot infections: a pilot study
nature.com - March 22 at 9:21 AM
DateCompanyBrokerageAction
3/17/2021STERISKeyCorpBoost Price Target
1/20/2021STERISRaymond JamesReiterated Rating
1/13/2021STERISRobert W. BairdBoost Price Target
11/20/2020STERISNeedham & Company LLCReiterated Rating
10/8/2020STERISJMP SecuritiesBoost Price Target
10/7/2020STERISStephensBoost Price Target
2/12/2020STERISNorthcoast ResearchReiterated Rating
12/6/2018STERISSidotiBoost Price Target
3/31/2021Smith & NephewBarclaysReiterated Rating
2/23/2021Smith & NephewBerenberg BankReiterated Rating
2/22/2021Smith & NephewJPMorgan Chase & Co.Reiterated Rating
2/22/2021Smith & NephewCredit Suisse GroupReiterated Rating
2/22/2021Smith & NephewCommerzbankDowngrade
2/19/2021Smith & NephewCanaccord GenuityLower Price Target
12/18/2020Smith & NephewSanford C. BernsteinUpgrade
12/9/2020Smith & NephewMorgan StanleyReiterated Rating
7/29/2020Smith & NephewBank of AmericaUpgrade
6/5/2020Smith & NephewBNP ParibasDowngrade
6/5/2020Smith & NephewExane BNP ParibasDowngrade
(Data available from 4/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.